Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study.

Pfefferbaum A, Rogosa DA, Rosenbloom MJ, Chu W, Sassoon SA, Kemper CA, Deresinski S, Rohlfing T, Zahr NM, Sullivan EV.

Neurobiol Aging. 2014 Jul;35(7):1755-68. doi: 10.1016/j.neurobiolaging.2014.01.008. Epub 2014 Jan 13.

2.

Reverse-engineering the genetic circuitry of a cancer cell with predicted intervention in chronic lymphocytic leukemia.

Vallat L, Kemper CA, Jung N, Maumy-Bertrand M, Bertrand F, Meyer N, Pocheville A, Fisher JW 3rd, Gribben JG, Bahram S.

Proc Natl Acad Sci U S A. 2013 Jan 8;110(2):459-64. doi: 10.1073/pnas.1211130110. Epub 2012 Dec 24.

3.

Regional brain structural dysmorphology in human immunodeficiency virus infection: effects of acquired immune deficiency syndrome, alcoholism, and age.

Pfefferbaum A, Rosenbloom MJ, Sassoon SA, Kemper CA, Deresinski S, Rohlfing T, Sullivan EV.

Biol Psychiatry. 2012 Sep 1;72(5):361-70. doi: 10.1016/j.biopsych.2012.02.018. Epub 2012 Mar 27.

4.

Cardiothoracic CT angiography: current contrast medium delivery strategies.

Weininger M, Barraza JM, Kemper CA, Kalafut JF, Costello P, Schoepf UJ.

AJR Am J Roentgenol. 2011 Mar;196(3):W260-72. doi: 10.2214/AJR.10.5814. Review.

PMID:
21343473
5.

Pontocerebellar contribution to postural instability and psychomotor slowing in HIV infection without dementia.

Sullivan EV, Rosenbloom MJ, Rohlfing T, Kemper CA, Deresinski S, Pfefferbaum A.

Brain Imaging Behav. 2011 Mar;5(1):12-24. doi: 10.1007/s11682-010-9107-y.

6.

A personalized and optimal approach for dosing contrast material at coronary computed tomography angiography.

Kalafut JF, Kemper CA, Suryani P, Schoepf U.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:3521-4. doi: 10.1109/IEMBS.2009.5334533.

PMID:
19964805
7.

Frontostriatal fiber bundle compromise in HIV infection without dementia.

Pfefferbaum A, Rosenbloom MJ, Rohlfing T, Kemper CA, Deresinski S, Sullivan EV.

AIDS. 2009 Sep 24;23(15):1977-85. doi: 10.1097/QAD.0b013e32832e77fe.

8.

Lactic acidosis in Africans receiving HAART.

Kemper CA.

AIDS Alert. 2007 Sep;22(9):106-8. No abstract available.

PMID:
18411465
9.

A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients.

Best BM, Goicoechea M, Witt MD, Miller L, Daar ES, Diamond C, Tilles JG, Kemper CA, Larsen R, Holland DT, Sun S, Jain S, Wagner G, Capparelli EV, McCutchan JA, Haubrich RH; California Collaborative Treatment Group 578 Study Team.

J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):433-42.

PMID:
17786128
10.

Upper and lower limb motor impairments in alcoholism, HIV infection, and their comorbidity.

Fama R, Eisen JC, Rosenbloom MJ, Sassoon SA, Kemper CA, Deresinski S, Pfefferbaum A, Sullivan EV.

Alcohol Clin Exp Res. 2007 Jun;31(6):1038-44. Epub 2007 Mar 31.

PMID:
17403062
11.

Alcoholism, HIV infection, and their comorbidity: factors affecting self-rated health-related quality of life.

Rosenbloom MJ, Sullivan EV, Sassoon SA, O'Reilly A, Fama R, Kemper CA, Deresinski S, Pfefferbaum A.

J Stud Alcohol Drugs. 2007 Jan;68(1):115-25.

PMID:
17149525
12.

Contribution of alcoholism to brain dysmorphology in HIV infection: effects on the ventricles and corpus callosum.

Pfefferbaum A, Rosenbloom MJ, Rohlfing T, Adalsteinsson E, Kemper CA, Deresinski S, Sullivan EV.

Neuroimage. 2006 Oct 15;33(1):239-51. Epub 2006 Jul 31.

PMID:
16877010
13.

Cognitive-behavioral intervention to enhance adherence to antiretroviral therapy: a randomized controlled trial (CCTG 578).

Wagner GJ, Kanouse DE, Golinelli D, Miller LG, Daar ES, Witt MD, Diamond C, Tilles JG, Kemper CA, Larsen R, Goicoechea M, Haubrich RH.

AIDS. 2006 Jun 12;20(9):1295-302.

PMID:
16816559
14.

Body image in patients with HIV/AIDS: assessment of a new psychometric measure and its medical correlates.

Martinez SM, Kemper CA, Diamond C, Wagner G; California Collaborative Treatment Group.

AIDS Patient Care STDS. 2005 Mar;19(3):150-6.

PMID:
15798382
15.

Capturing intraoperative deformations: research experience at Brigham and Women's Hospital.

Warfield SK, Haker SJ, Talos IF, Kemper CA, Weisenfeld N, Mewes AU, Goldberg-Zimring D, Zou KH, Westin CF, Wells WM, Tempany CM, Golby A, Black PM, Jolesz FA, Kikinis R.

Med Image Anal. 2005 Apr;9(2):145-62. Epub 2004 Dec 30. Review.

PMID:
15721230
16.

A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575.

Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Tilles JG, Forthal DN, Leedom J, Leibowitz M, McCutchan JA, Richman DD; California Collaborative Treatment Group.

AIDS. 2005 Feb 18;19(3):295-302.

PMID:
15718840
17.

The correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients.

Yasuda JM, Miller C, Currier JS, Forthal DN, Kemper CA, Beall GN, Tilles JG, Capparelli EV, McCutchan JA, Haubrich RH; California Collaborative Treatment Group.

Antivir Ther. 2004 Oct;9(5):753-61.

PMID:
15535413
18.

Safety and immunogenicity of hepatitis A vaccine in human immunodeficiency virus-infected patients: a double-blind, randomized, placebo-controlled trial.

Kemper CA, Haubrich R, Frank I, Dubin G, Buscarino C, McCutchan JA, Deresinski SC; California Collaborative Treatment Group.

J Infect Dis. 2003 Apr 15;187(8):1327-31. Epub 2003 Mar 24.

PMID:
12696015
19.

The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis.

Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Forthal DN, Leedom J, Leibowitz M, Whitcomb JM, Richman D, McCutchan JA; California Collaborative Treatment Group.

AIDS. 2002 Oct 18;16(15):F33-40.

PMID:
12370520
20.

Azithromycin prophylaxis during a hospitalwide outbreak of a pertussis-like illness.

Martinez SM, Kemper CA, Haiduven D, Cody SH, Deresinski SC.

Infect Control Hosp Epidemiol. 2001 Dec;22(12):781-3.

PMID:
11876458
21.

A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy.

Haubrich RH, Currier JS, Forthal DN, Beall G, Kemper CA, Johnson D, Dubé MP, Hwang J, Leedom JM, Tilles J, McCutchan JA; California Collaborative Treatment Group.

Clin Infect Dis. 2001 Oct 1;33(7):1060-8. Epub 2001 Sep 5.

PMID:
11528581
22.

Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.

Kemper CA, Witt MD, Keiser PH, Dubé MP, Forthal DN, Leibowitz M, Smith DS, Rigby A, Hellmann NS, Lie YS, Leedom J, Richman D, McCutchan JA, Haubrich R; California Collaborative Treatment Group #575 Team.

AIDS. 2001 Mar 30;15(5):609-15.

PMID:
11316998
23.

Frequency of cutaneous reactions on rechallenge with nevirapine and delavirdine.

Gangar M, Arias G, O'Brien JG, Kemper CA.

Ann Pharmacother. 2000 Jul-Aug;34(7-8):839-42.

PMID:
10928391
24.

Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. California Collaborative Treatment Group.

Dunne MW, Bozzette S, McCutchan JA, Dubé MP, Sattler FR, Forthal D, Kemper CA, Havlir D.

Lancet. 1999 Sep 11;354(9182):891-5.

PMID:
10489947
25.

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group.

Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN, Johnson D, Dubé MP, Hwang JY, McCutchan JA.

AIDS. 1999 Jun 18;13(9):1099-107.

PMID:
10397541
26.

Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.

Dubé MP, Torriani FJ, See D, Havlir DV, Kemper CA, Leedom JM, Tilles JG, McCutchan JA, Sattler FR.

Clin Infect Dis. 1999 Jan;28(1):136-8.

PMID:
10028084
27.

Mediterranean spotted fever in travelers from the United States.

Kemper CA, Deresinski S.

J Travel Med. 1998 Sep;5(3):158. No abstract available.

28.

Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.

Havlir DV, Dubé MP, McCutchan JA, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Kumar PN, White AC Jr, Witt MD, Nightingale SD, Sepkowitz KA, MacGregor RR, Cheeseman SH, Torriani FJ, Zelasky MT, Sattler FR, Bozzette SA.

Clin Infect Dis. 1998 Dec;27(6):1369-75.

PMID:
9868644
29.

Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial.

Kemper CA, Kent G, Burton S, Deresinski SC.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):367-72.

PMID:
9833745
30.

The prevalence of measles antibody in human immunodeficiency virus-infected patients in northern California.

Kemper CA, Gangar M, Arias G, Kane C, Deresinski SC.

J Infect Dis. 1998 Oct;178(4):1177-80.

PMID:
9806055
32.

Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.

Lalezari JP, Holland GN, Kramer F, McKinley GF, Kemper CA, Ives DV, Nelson R, Hardy WD, Kuppermann BD, Northfelt DW, Youle M, Johnson M, Lewis RA, Weinberg DV, Simon GL, Wolitz RA, Ruby AE, Stagg RJ, Jaffe HS.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 1;17(4):339-44.

PMID:
9525435
33.

A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group.

Dubé MP, Sattler FR, Torriani FJ, See D, Havlir DV, Kemper CA, Dezfuli MG, Bozzette SA, Bartok AE, Leedom JM, Tilles JG, McCutchan JA.

J Infect Dis. 1997 Nov;176(5):1225-32.

PMID:
9359722
34.

Pulmonary disease in selected protozoal infections.

Kemper CA.

Semin Respir Infect. 1997 Jun;12(2):113-21. Review.

PMID:
9195676
35.

Travels with HIV: the compliance and health of HIV-infected adults who travel.

Kemper CA, Linett A, Kane C, Deresinski SC.

Int J STD AIDS. 1997 Jan;8(1):44-9.

PMID:
9043981
36.

Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.

Havlir DV, Dubé MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Lavelle JP, White AC Jr, Witt MD, Bozzette SA, McCutchan JA.

N Engl J Med. 1996 Aug 8;335(6):392-8.

37.

Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study.

Mohle-Boetani JC, Koehler JE, Berger TG, LeBoit PE, Kemper CA, Reingold AL, Plikaytis BD, Wenger JD, Tappero JW.

Clin Infect Dis. 1996 May;22(5):794-800.

PMID:
8722933
38.

Treatment of Myocardium avium complex infection: does the beige mouse model predict therapeutic outcome in humans?

Sison JP, Yao Y, Kemper CA, Hamilton JR, Brummer E, Stevens DA, Deresinski SC.

J Infect Dis. 1996 Mar;173(3):750-3.

PMID:
8627046
39.

Treatment of Mycobacterium avium complex infection: do the results of in vitro susceptibility tests predict therapeutic outcome in humans?

Sison JP, Yao Y, Kemper CA, Hamilton JR, Brummer E, Stevens DA, Deresinski SC.

J Infect Dis. 1996 Mar;173(3):677-83.

PMID:
8627032
40.

Interest groups.

Kemper CA, Fry EM.

PDA J Pharm Sci Technol. 1995 Sep-Oct;49(5):203. No abstract available.

PMID:
7489191
41.

Genotypic analysis of pseudoepidemic due to contamination of Hanks' balanced salt solution with Candida parapsilosis.

Deresinski SC, Clemons KV, Kemper CA, Roesch K, Walton B, Stevens DA.

J Clin Microbiol. 1995 Aug;33(8):2224-6.

42.

Frequency of Travel of Adults Infected with HIV.

Kemper CA, Linett A, Kane C, Deresinski SC.

J Travel Med. 1995 Jun 1;2(2):85-88.

43.

Disseminated acanthamoeba infection in patients with AIDS: case reports and review.

Sison JP, Kemper CA, Loveless M, McShane D, Visvesvara GS, Deresinski SC.

Clin Infect Dis. 1995 May;20(5):1207-16. Review.

PMID:
7620001
44.

Computer-based screening of patients with HIV/AIDS for clinical-trial eligibility.

Carlson RW, Tu SW, Lane NM, Lai TL, Kemper CA, Musen MA, Shortliffe EH.

Online J Curr Clin Trials. 1995 Mar 28;Doc No 179:[3347 words; 32 paragraphs].

PMID:
7719564
45.

Mycobacterium avium complex infection in AIDS.

Kemper CA, Deresinski SC.

AIDS Clin Rev. 1995-1996:153-228. Review. No abstract available.

PMID:
7488555
46.

Transient bacteremia due to Mycobacterium avium complex in patients with AIDS.

Kemper CA, Havlir D, Bartok AE, Kane C, Camp B, Lane N, Deresinski SC.

J Infect Dis. 1994 Aug;170(2):488-93.

PMID:
8035044
47.

The individual microbiologic effect of three antimycobacterial agents, clofazimine, ethambutol, and rifampin, on Mycobacterium avium complex bacteremia in patients with AIDS.

Kemper CA, Havlir D, Haghighat D, Dubé M, Bartok AE, Sison JP, Yao Y, Yangco B, Leedom JM, Tilles JG, et al.

J Infect Dis. 1994 Jul;170(1):157-64.

PMID:
8014492
48.

Progressive immunodeficiency due to infection with human immunodeficiency virus does not lead to waning immunity to measles in a cohort of homosexual men.

Zolopa AR, Kemper CA, Shiboski S, Hamilton JR, Moss AR, Deresinski SC.

Clin Infect Dis. 1994 Apr;18(4):636-8.

PMID:
8038324
49.
50.

Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS.

Kemper CA, Hostetler JS, Follansbee SE, Ruane P, Covington D, Leong SS, Deresinski SC, Stevens DA.

Clin Infect Dis. 1993 Sep;17(3):344-52. Review.

PMID:
8218674

Supplemental Content

Loading ...
Support Center